Soleno Therapeutics Inc (SLNO)
Net Income Growth
171.68%
Quarterly · Period ending:
SLNO Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported171.68%period ending
Latest reported171.68%period ending
SLNO Quarterly Net Income YoY % (-182.23% → 171.68%)
Year-over-year change
High-resolution chart · PNG
SLNO net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 171.6835% | |
| 177.4499% | |
| 133.9524% | |
| 78.457% | |
| -104.5658% | |
| -395.5914% | |
| -605.4231% | |
| -157.8643% | |
| -156.0795% | |
| -105.9059% | |
| -77.12% | |
| -26.0223% | |
| -45.9818% | |
| -93.9887% | |
| 24.6683% | |
| 38.7969% | |
| 36.0733% | |
| 0.8415% | |
| 4.7396% | |
| -48.8082% | |
| -52.8508% | |
| 80.4991% | |
| -1,061.1924% | |
| 26.219% | |
| 16.6714% | |
| -5,660.8365% | |
| 132.4927% | |
| -31.0462% | |
| -87.217% | |
| 105.2334% | |
| 27.7338% | |
| -92.5618% | |
| -30.0658% | |
| -92.3082% | |
| -37.6727% | |
| -12.895% | |
| 9.4701% | |
| 8.1325% | |
| 16.4895% | |
| -286.7624% | |
| 72.629% | |
| 63.7892% | |
| -37.6097% | |
| 167.3469% | |
| -1,297.2286% | |
| -706.3197% | |
| -50.5031% | |
| -29.4825% | |
| -182.2344% |